Late recognition of SARS in nosocomial outbreak, Toronto

Emerging Infectious Diseases

Volumn 11, Issue 2, 2005, Pages 322-325

  Wong, Thomas ^a,b   Wallington, Tamara ^c   McDonald, L Clifford ^d   Abbas, Zahid ^a   Christian, Michael ^b   Low, Donald E ^b   Gravel, Denise ^a   Ofner, Marianna ^a,b   Mederski, Barbara ^e   Berger, Lisa ^c   Hansen, Lisa ^a   Harrison, Cheryl ^e   King, Arlene ^a   Yaffe, Barbara ^c   Tam, Theresa ^a  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO PUBLIC HEALTH   (Canada)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e NORTH YORK GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CANADA; EARLY DIAGNOSIS; EPIDEMIOLOGICAL DATA; FEMALE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; LABORATORY DIAGNOSIS; MALE; REINFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SEROEPIDEMIOLOGY; SEVERE ACUTE RESPIRATORY SYNDROME; SYMPTOMATOLOGY; VIRUS DETECTION; VIRUS TRANSMISSION; WARD;

EID: 13744260305     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1102.040607     Document Type: Review

References (15)

1. Poutanen SM, Low DE, Henry B, Finklestein S, Rose D, Green K, et al. Identification of severe acute respiratory syndrome in Canada. N Engl J Med. 2003;348:1995-2005.
2. Varia M, Wilson S, Sarwal S, McGeer A, Gournis E, Galansis E, et al. Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto, Canada. CMAJ. 2003;169:285-92.
3. World Health Organization. Case definitions for severe acute respiratory syndrome. [cited 2004 May 18]. Available from http://www.who.int/csr/sars/ casedefinition/en/
4. Peiris JS, Lai ST, Poon LL, Guan Y, Yam LYC, Lim W, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 2003;361:1319-25.
5. World Health Organization. Recommendations for laboratories testing by PCR for presence of SARS coronavirus-RNA. [cited 2004 May 18]. Available from www.who.int/csr/sars/coronarecommendations/en/index.html
6. Booth CM, Matukas LM, Tomlinson GA, Rachlis AR, Ros DB, Dwosh HA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003;289:2801-9.
7. Lee N, Hui D, Wu A,Chan P, Cameron P, Joynt GM, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348:1986-94.
8. Tsang KW, Ho PL, Ooi GC, Yee WK, Wang T, Chan-Yeung M, et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348:1977-85.
9. Jernigan JA, Low DE, Hefland RF. Combining clinical and epidemiologic features for early recognition of SARS. Emerg Infect Dis. 2004;10:327-33.
10. Klinger JR, Sanchez MP, Curtin LA, Durkin M, Matyas B. Multiple cases of life-threatening adenovirus pneumonia in a mental health care center. Am J Respir Crit Care Med. 1998;157:645-9.
11. Rainer TH, Chan PK, Ip M, Lee N, Hui DS, Smit D, et al. The spectrum of severe acute respiratory syndrome-associated coronavirus infection. Ann Intern Med. 2004;140:614-9.
12. Peiris JS, Chu CM, Cheng VC, Chan KS, Hung IFN, Poon LLM, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;361:1767-72.
13. Loutfy MR, Wallington T, Rutledge T, Mederski B, Rose K, Kwolek S, et al. Hospital preparedness and SARS. Emerg Infect Dis. 2004;10:771-6.
14. McDonald LC, Simor AE, Su IJ, Maloney S, Ofner M, Chen KT, et al. SARS in healthcare facilities. Emerg Infect Dis. 2004;10:777-81.
15. Muller MP, Tomlinson GA, Matukas LM, Detsky AS, McGeer A, Low DE, et al. Discriminative ability of laboratory parameters in severe acute respiratory syndrome (SARS) [abstract V-796b]. 43rd Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy; 2003 Sep 14-17; Chicago. Washington: American Society for Microbiology; 2003.